Minerva Neurosciences, Inc (NERV) Social Stream



Minerva Neurosciences, Inc (NERV): $2.24

0.03 (+1.36%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add NERV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#185 of 359

in industry

MINERVA NEUROSCIENCES INC (NERV) Price Targets From Analysts

Use the tables below to see what analysts covering MINERVA NEUROSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $10 $3 $6.5 $7.62 -14.7%
2022-03-04 2 $40 $40 $40 $7.62 424.93%
2022-08-23 2 $24 $24 $24 $7.62 214.96%
2022-10-18 3 $8 $8 $8 $7.62 4.99%
2022-11-10 3 $8 $8 $8 $7.62 4.99%
2023-05-16 2 $8 $8 $8 $7.62 4.99%
2023-11-10 2 $11 $11 $11 $7.62 44.36%

The Trend in the Analyst Price Target


NERV's average price target has moved up $4 over the prior 26 months.

NERV reports an average of 139.17% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-09 2 8 8 8 1.81 341.99%
2023-05-16 2 8 8 8 5.64 41.84%
2023-08-02 2 11 11 11 10.52 4.56%
2023-11-10 2 11 11 11 4.10 168.29%

NERV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


Over the past 26 weeks, NERV's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NERV as an investment opportunity.

  • In terms of how MINERVA NEUROSCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 48.03% of that group.
  • NERV has a lower variance in analysts' estimates than -110.12% of all US stocks.
  • In terms of how MINERVA NEUROSCIENCES INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 375.64% of that group.
  • In the context of stocks in the small market cap category, MINERVA NEUROSCIENCES INC's average analyst price target is greater than 374.76% of them.

Stocks similar to MINERVA NEUROSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EGRX, ELDN, and ARDX.

Is NERV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!